Argenx
OrganizationHeard on podcasts recently
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. The company focuses on the development of antibody therapies for the treatment of autoimmune diseases and cancer, with a primary emphasis on orphan drugs.
Discussed inMarkets100%
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Argenx per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 13 | 0.01‰ | 1 |
| Oct 16 | 0.03‰ | 2 |
| Oct 20 | 0.03‰ | 1 |
| Nov 6 | 0.01‰ | 1 |
| Nov 10 | 0.02‰ | 1 |
Discussed alongside
Names that come up in the same conversations as Argenx.
Embed this
Paste this on your site to show Argenx's current trend:
<iframe src="https://podlume.ai/embed/e/argenx" width="360" height="220" style="border:0" loading="lazy" title="Argenx on PodLume Trends"></iframe>